Literature DB >> 21220998

Prevention of post-cardiopulmonary bypass acute kidney injury by endothelin A receptor blockade.

Nishith N Patel1, Tibor Toth, Ceri Jones, Hua Lin, Paramita Ray, Sarah J George, Gavin Welsh, Simon C Satchell, Philippa Sleeman, Gianni D Angelini, Gavin J Murphy.   

Abstract

OBJECTIVE: The aim of this study was to determine whether administration of a specific endothelin A receptor antagonist, sitaxsentan sodium, would prevent the development of post-cardiopulmonary bypass acute kidney injury in swine.
DESIGN: Experimental study.
SETTING: Cardiovascular Research Institute.
INTERVENTIONS: Adult pigs (n = 8 per group) were randomized to undergo a sham procedure, cardiopulmonary bypass, or cardiopulmonary bypass plus administration of endothelin A receptor antagonist (RA), with recovery and reassessment at 24 hrs.
MEASUREMENTS AND MAIN RESULTS: Cardiopulmonary bypass resulted in a significant reduction in creatinine clearance relative to sham pigs (mean difference for cardiopulmonary bypass vs. sham, -50.3 mL/min [95% confidence interval -89.2 to -11.4 mL/min], p = .008). This was reversed by the administration of endothelin A RA during cardiopulmonary bypass (mean difference for cardiopulmonary bypass + endothelin A RA vs. cardiopulmonary bypass, +43.3 mL/min [95% confidence interval +3.3 to +83.4 mL/min], p = .030). Cardiopulmonary bypass also resulted in a significant rise in the specific urinary biomarker of acute kidney injury interleukin-18 compared to sham procedures (mean difference +209 pg/mL [95% confidence interval +119 to +299 pg/mL], p < .001) that was reversed by endothelin A receptor antagonist administration. Post-cardiopulmonary bypass kidney injury was associated with vascular endothelial injury and dysfunction, reduced nitric oxide bioavailability, inflammation, and a significant increase in the expression of the paracrine vasoconstrictors adenosine and endothelin-1. In post-cardiopulmonary bypass kidneys at 24 hrs there was persistent hypoxia at the level of the outer medulla, cortical adenosine triphosphate depletion, and evidence of proximal tubule epithelial cell stress manifest as phenotypic change. There was no evidence of acute tubular necrosis. Administration of endothelin A RA to cardiopulmonary bypass pigs reversed endothelial dysfunction, regional hypoxia, inflammation, and tubular changes.
CONCLUSION: In this model, post-cardiopulmonary bypass acute kidney injury is associated with endothelial dysfunction, regional tissue hypoxia, and proximal tubular epithelial cell stress but not acute tubular necrosis. Antagonism of the endothelin-1 A receptor reversed these changes and may represent a therapeutic target for the prevention of post-cardiac surgery acute kidney injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220998     DOI: 10.1097/CCM.0b013e318206d563

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

Review 1.  Targeting Endogenous Repair Pathways after AKI.

Authors:  Benjamin D Humphreys; Vincenzo Cantaluppi; Didier Portilla; Kai Singbartl; Li Yang; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-11-18       Impact factor: 10.121

2.  A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study.

Authors:  Arne Ring; Tom Morris; Marcin Wozniak; Nikol Sullo; William Dott; Veerle Verheyden; Tracy Kumar; Nigel Brunskill; Rakesh Vaja; Gavin J Murphy
Journal:  Br J Clin Pharmacol       Date:  2016-12-01       Impact factor: 4.335

Review 3.  Bridging translation for acute kidney injury with better preclinical modeling of human disease.

Authors:  Nataliya I Skrypnyk; Leah J Siskind; Sarah Faubel; Mark P de Caestecker
Journal:  Am J Physiol Renal Physiol       Date:  2016-03-09

4.  Metabolomic profiling demonstrates evidence for kidney and urine metabolic dysregulation in a piglet model of cardiac surgery-induced acute kidney injury.

Authors:  Jesse A Davidson; Justin Robison; Ludmila Khailova; Benjamin S Frank; James Jaggers; Richard J Ing; Scott Lawson; John Iguidbashian; Eiman Ali; Amy Treece; Danielle E Soranno; Suzanne Osorio-Lujan; Jelena Klawitter
Journal:  Am J Physiol Renal Physiol       Date:  2022-05-09

Review 5.  Endothelin antagonists in hypertension and kidney disease.

Authors:  Kevin E C Meyers; Christine Sethna
Journal:  Pediatr Nephrol       Date:  2012-10-16       Impact factor: 3.714

6.  Reversal of anemia with allogenic RBC transfusion prevents post-cardiopulmonary bypass acute kidney injury in swine.

Authors:  Nishith N Patel; Hua Lin; Tibor Toth; Gavin I Welsh; Ceri Jones; Paramita Ray; Simon C Satchell; Philippa Sleeman; Gianni D Angelini; Gavin J Murphy
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-08

7.  High fat feeding promotes obesity and renal inflammation and protects against post cardiopulmonary bypass acute kidney injury in swine.

Authors:  Philippa Sleeman; Nishith N Patel; Hua Lin; Graham J Walkden; Paramita Ray; Gavin I Welsh; Simon C Satchell; Gavin J Murphy
Journal:  Crit Care       Date:  2013-10-31       Impact factor: 9.097

8.  Changes in renal medulla gene expression in a pre-clinical model of post cardiopulmonary bypass acute kidney injury.

Authors:  Mohamed T Ghorbel; Nishith N Patel; Maimuna Sheikh; Gianni D Angelini; Massimo Caputo; Gavin J Murphy
Journal:  BMC Genomics       Date:  2014-10-21       Impact factor: 3.969

9.  Preoperative Serum GDF-15, Endothelin-1 Levels, and Intraoperative Factors as Short-Term Operative Risks for Patients Undergoing Cardiovascular Surgery.

Authors:  Takashi Kato; Toshiaki Nakajima; Taira Fukuda; Ikuko Shibasaki; Takaaki Hasegawa; Koji Ogata; Hironaga Ogawa; Shotaro Hirota; Hirotaka Ohashi; Shunsuke Saito; Yusuke Takei; Masahiro Tezuka; Masahiro Seki; Toshiyuki Kuwata; Masashi Sakuma; Shichiro Abe; Shigeru Toyoda; Teruo Inoue; Hirotsugu Fukuda
Journal:  J Clin Med       Date:  2021-05-02       Impact factor: 4.241

Review 10.  Renal protection in cardiovascular surgery.

Authors:  Nora Di Tomasso; Fabrizio Monaco; Giovanni Landoni
Journal:  F1000Res       Date:  2016-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.